Session information

Morning Seminar

MS2-12 Importance of Iron Chelation Therapy in Lower-risk MDS and Scheme to Prevent Overlook

Sat. Oct 12, 2019 7:55 AM - 8:40 AM No.12 (Tokyo International Forum, 5F G510)

Chairs: Akihiko Gotoh（Department of Hematology, Tokyo Medical University）, Shin Fujisawa（Department of Hematology, Yokohama City University Medical Center）

Sponsor: Novartis Pharma K.K.

[MS2-12] Importance of Iron Chelation Therapy in Lower-risk MDS and Scheme to Prevent Overlook

Yasuyoshi Morita¹, Eisaburo Sueoka² (1.Division of Hematology and Rheumatology, Department of Internal Medicine, Faculty of Medicine Kindai University, 2.Department of Clinical Laboratory Medicine, Faculty of Medicine, Saga University)

▲